| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 108, 24-37, Copyright © 1982 by American Society for Investigative Pathology
REGULAR ARTICLES |
RE Anderson, S Tokuda, WL Williams and NL Warner
Whole-body exposure of A/J mice to low doses (5-25 rads) of ionizing radiation immediately prior to the inoculation of 10(4) Sarcoma I (SaI) cells results in smaller tumors than are observed in sham-irradiated control animals. The irradiated group also contains a greater proportion of mice that fail to develop tumors or that demonstrate tumor regression. Low-dose augmentation is 1) less pronounced in recipients that have undergone splenectomy; 2) not evident in adult thymectomized-lethally irradiated-bone-marrow-restored (ATxXBM) animals, where the opposite effect is seen (eg, low-dose enhancement of tumor growth); and 3) abolished by the administration of normal syngeneic spleen cells unless the latter have been depleted of T cells. On this basis, a very radiosensitive T cell with suppressor activity is implicated in this phenomenon. Low-dose exposure at various times prior to tumor inoculation suggests that this cell regenerates in 5-10 days after irradiation.
This article has been cited by other articles:
![]() |
G. Sgouros, S. J. Knox, M. C. Joiner, W. F. Morgan, and A. I. Kassis MIRD Continuing Education: Bystander and Low Dose-Rate Effects: Are These Relevant to Radionuclide Therapy? J. Nucl. Med., October 1, 2007; 48(10): 1683 - 1691. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |